Dachaigh › Cairtean uaine › Simulations Plus, Inc.
Simulations Plus, Inc.: sponsorachadh cairt uaine (PERM)
Chuir Simulations Plus, Inc. 4 iarrtasan dearbhaidh obrach PERM a chaidh a dhearbhadh ann am bliadhnaichean ionmhais 2024–2026; dearbhte: 4. Tuarastal meadhanach tairgte $103,062; ùine mheadhanach bhon chur-a-steach chun dearbhadh: 499 làithean.
Iarrtasan PERM4
Dearbhte4
Tuarastal meadhanach a chaidh a thabhann$103,062
Làithean meadhanach gu dearbhadh499
Mar-thà ag obair don neach-fastaidh100%
Luchd-obrach (mar a chaidh a chur a-steach)132
Ann an gnìomhachas bho1996
Seòladh an neach-fhastaidhLancaster, CA
Tuarastalan H-1B aig Simulations Plus, Inc. →
Tiotalan dreuchd
| Tiotal dreuchd | Iarrtasan PERM | Tuarastal meadhanach |
|---|---|---|
| Pharmacometrician | 1 | $75,000 |
| Business Development Specialist | 1 | $138,000 |
| Senior Scientist Developer | 1 | $120,000 |
| Sr. Marketing Research Analyst | 1 | $86,125 |
Làraich obrach
Gnìomhan
- Medical Scientists, Except Epidemiologists1
- Sales Engineers1
- Chemists1
- Market Research Analysts and Marketing Specialists1
Co-dhùnaidhean as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Air a cho-dhùnadh | Inbhe | Làithean |
|---|---|---|---|---|---|---|
| Sr. Marketing Research Analyst | $86,125–$89,475 | Lancaster, CA | 4 Gearr 2025 | 11 Cèit 2026 | Dearbhte | 461 |
| Senior Scientist Developer | $120,000–$140,000 | Lancaster, CA | 15 Samh 2023 | 4 Gibl 2025 | Dearbhte, a’ dol seachad | 506 |
| Business Development Specialist | $138,000–$165,000 | Lancaster, CA | 24 Dàmh 2023 | 27 Gearr 2025 | Dearbhte, a’ dol seachad | 492 |
| Pharmacometrician | $75,000–$95,000 | Buffalo, NY | 3 Dàmh 2023 | 26 Gearr 2025 | Dearbhte, a’ dol seachad | 512 |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications. PERM certification is one step toward a green card; USCIS decides the petition. Not legal advice. Source: U.S. Department of Labor, OFLC PERM Disclosure Data, fiscal years 2024–2026 (latest decision 30 Ògmh 2026).